The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome
Open accessAbstract
CONTEXT: Recombinant human GH (rhGH) therapy in Prader-Willi syndrome (PWS) has been used by the medical community and advocated by parental support groups since its approval in the United States in 2000 and in Europe in 2001. Its use in PWS represents a unique therapeutic challenge that includes treating individuals with cognitive disability, varied therapeutic goals that are not focused exclusively on increased height, and concerns about potential life-threatening adverse events. OBJECTIVE: The aim of the study was to formulate recommendations for the use of rhGH in children and adult patients with PWS. EVIDENCE: We performed a systematic review of the clinical evidence in the pediatric population, including randomized controlled trials, comparative observational studies, and long-term studies (>3.5 y). Adult studies included randomized controlled trials of rhGH treatment for ≥ 6 months and uncontrolled trials. Safety data were obtained from case reports, clinical trials, and pharmaceutical registries. METHODOLOGY: Forty-three international experts and stakeholders followed clinical practice guideline development recommendations outlined by the AGREE Collaboration (www.agreetrust.org). Evidence was synthesized and graded using a comprehensive multicriteria methodology (EVIDEM) (http://bit.ly.PWGHIN). CONCLUSIONS: Following a multidisciplinary evaluation, preferably by experts, rhGH treatment should be considered for patients with genetically confirmed PWS in conjunction with dietary, environmental, and lifestyle interventions. Cognitive impairment should not be a barrier to treatment, and informed consent/assent should include benefit/risk information. Exclusion criteria should include severe obesity, uncontrolled diabetes mellitus, untreated severe obstructive sleep apnea, active cancer, or psychosis. Clinical outcome priorities should vary depending upon age and the presence of physical, mental, and social disability, and treatment should be continued for as long as demonstrated benefits outweigh the risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Department of Health, Education, and Welfare
Cooper, T. (1976) · Military Medicine · doi:10.1093/milmed/141.8.521 · Cited by 3,993
(2003) · Manual for Research Ethics Committees · doi:10.1017/cbo9780511550089.028 · Cited by 3,413
Charbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Cassidy, S. B., Schwartz, S., Miller, J. L., & Driscoll, D. J. (2012) · Genetics in Medicine · doi:10.1038/gim.0b013e31822bead0 · Cited by 1,452
Case Report and Literature Review
Spoden, J. E., Bumsted, R. M., & Warner, E. D. (1980) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348948008900320 · Cited by 1,094
Informed Consent, Parental Permission, and Assent in Pediatric Practice
Committee on Bioethics (1995) · Pediatrics · doi:10.1542/peds.95.2.314 · Cited by 956
Informed Consent, Parental Permission, and Assent in Pediatric Practice
Bartholome, W. G. (1995) · Pediatrics · doi:10.1542/peds.96.5.981 · Cited by 653
Cassidy, S. B., & Driscoll, D. J. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.165 · Cited by 591
Centre for Evidence Based Medicine
Badenoch, D., & Mbe (2003) · Cited by 586
August, G. P., Caprio, S., Fennoy, I., Freemark, M., Kaufman, F. R., Lustig, R. H., Silverstein, J. H., Speiser, P. W., Styne, D. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2458 · Cited by 524
Recommendations for the Diagnosis and Management of Prader-Willi Syndrome
Goldstone, A. P., Holland, A. J., Hauffa, B. P., Hokken-Koelega, A. C., & Tauber, M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0649 · Cited by 519
Self-citationConsensus Conference Statement
Buchwald, H. (2005) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2005.04.002 · Cited by 489 · cited 1×
“Restrictive bariatric surgery (gastric banding or bypass) Several surgical procedures Contradictory efficacy results Buchwald, 2005 (120) Induces weight loss by altering the digestive tract so that nutrients and fats are not absorbed by the body (stomach reduction and/or bypass) Limited weight reduction long term Anta…”
BackgroundCassidy, S. B. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.11.917 · Cited by 473
Nutritional phases in Prader–Willi syndrome
Miller, J. L., Lynn, C. H., Driscoll, D. C., Goldstone, A. P., Gold, J., Kimonis, V., Dykens, E., Butler, M. G., Shuster, J. J., & Driscoll, D. J. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33951 · Cited by 447
Endocrine Dysfunction in Prader-Willi Syndrome: A Review with Special Reference to GH
Burman, P., Ritzén, E. M., & Lindgren, A. C. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0447 · Cited by 404
Haqq, A. M., Farooqi, I. S., O’Rahilly, S., Stadler, D. D., Rosenfeld, R. G., Pratt, K. L., LaFranchi, S. H., & Purnell, J. Q. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021052 · Cited by 374
Growth hormone, the insulin-like growth factor axis, insulin and cancer risk
Clayton, P. E., Banerjee, I., Murray, P. G., & Renehan, A. G. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.171 · Cited by 364
Carel, J.-C., Ecosse, E., Landier, F., Meguellati-Hakkas, D., Kaguelidou, F., Rey, G., & Coste, J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1995 · Cited by 295
Chernausek, S. D., Backeljauw, P. F., Frane, J., Kuntze, J., Underwood, L. E., & for the GH Insensitivity Syndrome Collaborative Group (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1610 · Cited by 243
Prader-Willi Syndrome: Obesity due to Genomic Imprinting
G. Butler, M. (2011) · Current Genomics · doi:10.2174/138920211795677877 · Cited by 239
Evidence and Value: Impact on DEcisionMaking – the EVIDEM framework and potential applications
Goetghebeur, M. M., Wagner, M., Khoury, H., Levitt, R. J., Erickson, L. J., & Rindress, D. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-270 · Cited by 227
Takeda, A., Cooper, K., Bird, A., Baxter, L., Frampton, G., Gospodarevskaya, E., Welch, K., & Bryant, J. (2010) · Health Technology Assessment · doi:10.3310/hta14420 · Cited by 226
Benefits of Long-Term GH Therapy in Prader-Willi Syndrome: A 4-Year Study
Carrel, A. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1581 · Cited by 225
Carrel, A. L., Myers, S. E., Whitman, B. Y., Eickhoff, J., & Allen, D. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1389 · Cited by 209
Self-citationCarrel, A. L., Myers, S. E., Whitman, B. Y., & Allen, D. B. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70418-x · Cited by 207
Self-citationHealth Supervision for Children With Prader-Willi Syndrome
McCandless, S. E., & The Committee on Genetics (2011) · Pediatrics · doi:10.1542/peds.2010-2820 · Cited by 197
Review of 64 cases of death in children with Prader–Willi syndrome (PWS)
Tauber, M., Diene, G., Molinas, C., & Hébert, M. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32131 · Cited by 195
Self-citationGoldstone, A. P. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4330 · Cited by 194
Management of Prader-Willi Syndrome
(2006) · Springer eBooks · doi:10.1007/978-0-387-33536-0 · Cited by 191
Haqq, A. M., Stadler, D. D., Jackson, R. H., Rosenfeld, R. G., Purnell, J. Q., & LaFranchi, S. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021536 · Cited by 181
Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo
Greenway, F. L., Dunayevich, E., Tollefson, G., Erickson, J., Guttadauria, M., Fujioka, K., Cowley, M. A., & for the NB-201 Study Group (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1350 · Cited by 179
Sävendahl, L., Maes, M., Albertsson-Wikland, K., Borgström, B., Carel, J.-C., Henrard, S., Speybroeck, N., Thomas, M., Zandwijken, G., & Hokken-Koelega, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2882 · Cited by 179
High Prevalence of Central Adrenal Insufficiency in Patients with Prader-Willi Syndrome
de Lind van Wijngaarden, R. F. A., Otten, B. J., Festen, D. A. M., Joosten, K. F. M., de Jong, F. H., Sweep, F. C. G. J., & Hokken-Koelega, A. C. S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2294 · Cited by 165
De Lourdes Levy, M., Larcher, V., & Kurz, R. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1193-z · Cited by 164
Diene, G., Mimoun, E., Feigerlova, E., Caula, S., Molinas, C., Grandjean, H., Tauber, M., & French Reference Centre for PWS (2010) · Hormone Research in Paediatrics · doi:10.1159/000313377 · Cited by 162
Self-citationDopson, S., & Fitzgerald, L. (2005) · doi:10.1093/acprof:oso/9780199259014.001.0001 · Cited by 161
Myers, S. E., Whitman, B. Y., Carrel, A. L., Moerchen, V. A., Bekx, M. T., & Allen, D. B. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31468 · Cited by 157
Self-citationMyers, S. E., Carrel, A. L., Whitman, B. Y., & Allen, D. B. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.105369 · Cited by 155
Self-citationCarrel, A. L., Moerchen, V. A., Myers, S. E., Bekx, M. T., Whitman, B. Y., & Allen, D. B. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.08.002 · Cited by 153
Self-citationShort-Term Effects of Growth Hormone on Sleep Abnormalities in Prader-Willi Syndrome
Miller, J. L., Silverstein, J. H., Shuster, J. J., Driscoll, D. J., & Wagner, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1279 · Cited by 146
Lindgren, A., Hagenäs, L., Müller, J., Blichfeldt, S., Rosenborg, M., Brismar, T. B., & Ritzén, E. M. (1998) · Acta Paediatrica · doi:10.1080/08035259850157822 · Cited by 145
Critical Analysis of Bariatric Procedures in Prader‐Willi Syndrome
Scheimann, A. O., Butler, M. G., Gourash, L. M., Cuffari, C., & Klish, W. J. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000304458.30294.31 · Cited by 144
Siemensma, E. P. C., van Wijngaarden, R. F. A. T.-D. L., Festen, D. A. M., Troeman, Z., van der Velden, J. A. E. M., Otten, B. J., Rotteveel, J., Odink, R. J., Heus, G. C. B. B.-D., van Leeuwen, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1182 · Cited by 143
Festen, D. A. M., Wevers, M., Lindgren, A., Böhm, B., Otten, B. J., Wit, J. M., Duivenvoorden, H. J., & Hokken‐Koelega, A. C. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03126.x · Cited by 140
Tan, T., Vanderpump, M. P. J., Khoo, B. C. E., Patterson, M., Ghatei, M. A., & Goldstone, A. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0835 · Cited by 125
Long-term persistence with orlistat and sibutramine in a population-based cohort
Padwal, R. S., Kezouh, A., Levine, M. N., & Etminan, M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803631 · Cited by 125
Haqq, A. M., Stadler, D. D., Rosenfeld, R. G., Pratt, K. L., Weigle, D. S., Frayo, R. S., LAFRANCHI, S. H., Cummings, D. E., & Purnell, J. Q. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030205 · Cited by 124
Sopher, A. B., Jean, A. M., Zwany, S. K., Winston, D. M., Pomeranz, C. B., BELL, J. J., McMahon, D. J., Hassoun, A. A., Fennoy, I., & Oberfield, S. E. (2011) · Obesity · doi:10.1038/oby.2010.305 · Cited by 124
Lindgren, A., Hellström, L. G., Ritzén, E. M., & Milerad, J. (1999) · European Journal of Pediatrics · doi:10.1007/s004310051246 · Cited by 124
Festen, D. A. M., van Wijngaarden, R. D. L., Eekelen, M. V., Otten, B. J., Wit, J. M., Duivenvoorden, H. J., & Hokken-Koelega, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03228.x · Cited by 121
Cohen, P., Germak, J. A., Rogol, A. D., Weng, W., Kappelgaard, A., Rosenfeld, R. G., & on behalf of the American Norditropin Study Group (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2139 · Cited by 120
Lau, D. C. W. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070306 · Cited by 118
van Wijngaarden, R. F. A. D. L., Siemensma, E. P. C., Festen, D. A. M., Otten, B. J., van Mil, E., Rotteveel, J., Odink, R. J., Heus, G. C. B. B.-D., van Leeuwen, M., Haring, D. A. J. P., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0454 · Cited by 114
Haqq, A. M., Muehlbauer, M. J., Newgard, C. B., Grambow, S. C., & Freemark, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1733 · Cited by 114
Angulo, M., Castro-Magaña, M., Mazur, B., Canas, J. A., Vitollo, P., & Sarrantonio, M. J. (1996) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1996.9.3.393 · Cited by 112
Sudden death in growth hormone–treated children with Prader-Willi syndrome
Vliet, G. V., Deal, C., Crock, P., Robitaille, Y., & Oligny, L. L. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.09.049 · Cited by 108
Self-citationReus, L., Zwarts, M. J., van Vlimmeren, L. A., Willemsen, M. A. A. P., Otten, B. J., & der Sanden, M. W. G. N. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.015 · Cited by 108
Goetghebeur, M. M., Wagner, M., Khoury, H., Rindress, D., Grégoire, J., & Deal, C. (2010) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-8-4 · Cited by 105
Self-citationThe Italian National Survey for Prader–Willi syndrome: An epidemiologic study
Grugni, G., Crinò, A., Bosio, L., Corrias, A., Cuttini, M., Toni, T. D., Battista, E. D., Franzese, A., Gargantini, L., Greggio, N. A., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32133 · Cited by 101
Eiholzer, U., Gisin, R., Weinmann, C., Kriemler, S., Steinert, H. C., Torresani, T., ZACHMANN, M., & Prader, A. (1998) · European Journal of Pediatrics · doi:10.1007/s004310050832 · Cited by 98
Psychiatric illness in a cohort of adults with Prader-Willi syndrome
Sinnema, M., Boer, H., Collin, P. J. L., Maaskant, M. A., van Roozendaal, K. E. P., Schrander-Stumpel, C. T. R. M., & Curfs, L. (2011) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2011.02.027 · Cited by 97
Mogul, H. R., Lee, P., Whitman, B. Y., Zipf, W. B., Frey, M., Myers, S. E., Cahan, M., Pinyerd, B., & Southren, A. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2212 · Cited by 95
Höybye, C., Thoren, M., & Böhm, B. (2005) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2005.00641.x · Cited by 93
Self-citationBekx, M. T., Carrel, A. L., Shriver, T. C., Li, Z., & Allen, D. B. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00386-x · Cited by 92
Self-citationTauber, M., Barbeau, C., Jouret, B., Pienkowski, C., Malzac, P., Moncla, A., & ROCHICCIOLI, P. E. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053184 · Cited by 90
Self-citationSánchez-Ortiga, R., Klibanski, A., & Tritos, N. A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04303.x · Cited by 90
Growth Hormone Secretion in Prader‐Willi Syndrome
Costeff, H., Holm, V. A., Ruvalcaba, R. H. A., & Shaver, J. L. F. (1990) · Acta Paediatrica · doi:10.1111/j.1651-2227.1990.tb11383.x · Cited by 88
Zipf, W. B., & Berntson, G. G. (1987) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/46.2.277 · Cited by 86
Respiratory control in children with Prader-Willi syndrome
Schlüter, B., Buschatz, D., Trowitzsch, E., Aksu, F., & Andler, W. (1996) · European Journal of Pediatrics · doi:10.1007/s004310050555 · Cited by 85
Craig, M. E., Cowell, C. T. C. T., Larsson, P., Zipf, W. B., Reiter, E. O., Wikland, K. A., Ranke, M. B., Price, D. A., & on behalf of the KIGS International Board (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02570.x · Cited by 83
Waele, K. D., Ishkanian, S. L., Bogarin, R., Miranda, C. A., Ghatei, M. A., Bloom, S. R., Pacaud, D., & Chanoine, J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0462 · Cited by 80
van Wijngaarden, R. F. A. D. L., de Klerk, L. W. L., Festen, D. A. M., Duivenvoorden, H. J., Otten, B. J., & Hokken‐Koelega, A. C. S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1844 · Cited by 79
Five years of growth hormone treatment in children with Prader‐Willi syndrome
Lindgren, A., & Ritzén, E. M. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb14416.x · Cited by 76
Purtell, L., Sze, L., Loughnan, G., Smith, E., Herzog, H., Sainsbury, A., Steinbeck, K. S., Campbell, L. V., & Viardot, A. (2011) · Neuropeptides · doi:10.1016/j.npep.2011.06.001 · Cited by 76
Growth hormone treatment improves body composition in adults with Prader–Willi syndrome
Höybye, C., Hilding, A., Jacobsson, H., & Thorén, M. C. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01769.x · Cited by 75
Self-citationMetabolic syndrome in children with Prader–Willi syndrome: the effect of obesity
Brambilla, P., Crinò, A., Bedogni, G., Bosio, L., Cappa, M., Corrias, A., Delvecchio, M., Candia, S. D., Gargantini, L., Grechi, E., et al. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.10.004 · Cited by 75
Topiramate attenuates self-injurious behaviour in Prader–Willi syndrome
Shapira, N. A., Lessig, M. C., Murphy, T. K., Driscoll, D. J., & Goodman, W. K. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002833 · Cited by 73
Eiholzer, U., & l’Allemand, D. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023565 · Cited by 72
Child, C. J., Zimmermann, A. G., Scott, R. S., Cutler, G. B., Battelino, T., & Blum, W. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-3023 · Cited by 71
Long-Term Surveillance of Growth Hormone Therapy
Rosenfeld, R. G., Cohen, P., Robison, L. L., Bercu, B. B., Clayton, P., Hoffman, A. R., Radovick, S., Saenger, P. H., Savage, M. O., & Wit, J. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2294 · Cited by 70
Fatal Outcome of Sleep Apnoea in PWS during the Initial Phase of Growth Hormone Treatment
Eiholzer, U., Nordmann, Y., & l’Allemand, D. (2002) · Hormone Research in Paediatrics · doi:10.1159/000066478 · Cited by 69
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome
Sode-Carlsen, R., Farholt, S., Rabben, K. F., Bollerslev, J., Schreiner, T., Jurik, A. G., Christiansen, J. S., & Höybye, C. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.12.004 · Cited by 68
Self-citationPubarche and serum dehydroepiandrosterone sulphate levels in children with Prader–Willi syndrome
Siemensma, E. P. C., van Wijngaarden, R. F. A. D. L., Otten, B. J., de Jong, F. H., & Hokken-Koelega, A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03989.x · Cited by 65
Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology, Corrias, A., BELLONE, J., Beccaria, L., Bosio, L., Trifirò, G., Livieri, C., Ragusa, L., Salvatoni, A., Galera, M. A., et al. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343684 · Cited by 65
Sze, L., Purtell, L., Jenkins, A. B., Loughnan, G., Smith, E., Herzog, H., Sainsbury, A., Steinbeck, K. S., Campbell, L. V., & Viardot, A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0038 · Cited by 65
Cassidy, S. B., & McCandless, S. E. (2005) · Wiley eBooks · doi:10.1002/0471695998.mgs036 · Cited by 65
Sode-Carlsen, R., Farholt, S., Rabben, K. F., Bollerslev, J., Schreiner, T., Jurik, A. G., Christiansen, J. S., & Höybye, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0907 · Cited by 63
Self-citationChanging rates of genetic subtypes of Prader–Willi syndrome in the UK
Whittington, J. E., Butler, J., & Holland, A. J. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201716 · Cited by 61
Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome
Eiholzer, U., l’Allemand, D., Schlumpf, M., Rousson, V., Gasser, T., & Fusch, C. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.03.005 · Cited by 61
Quality of life and psychological well‐being in GH‐treated, adult PWS patients: a longitudinal study
Bertella, L., Mori, I., Grugni, G., Pignatti, R., Ceriani, F., Molinari, E., Ceccarelli, A., Sartório, A., Vettor, R., & Semenza, C. (2007) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2006.00878.x · Cited by 60
Plodkowski, R. A., Nguyen, Q., Sundaram, U., Nguyen, L. D., Chau, D., & Jeor, S. S. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902775750 · Cited by 55
Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome
Davies, P., Evans, S., Broomhead, S., Clough, H., Day, J. M. E., Laidlaw, A., & Barnes, N. D. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.78.5.474 · Cited by 55
Naltrexone for the treatment of obesity: review and update
Lee, M. W., & Fujioka, K. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903048959 · Cited by 51
Colmenares, A., Pinto, G., Taupin, P., Giuseppe, A., Odent, T., Trivin, C., Laborde, K., Souberbielle, J., & Polak, M. (2010) · Hormone Research in Paediatrics · doi:10.1159/000319709 · Cited by 50
Lindgren, A., Hagenäs, L., Müller, J., Blichfeldt, S., Rosenborg, M., Brismar, T. B., Ritzén, E. M., & Swedish National Growth Hormone Advisory Group (1997) · Acta Paediatrica · doi:10.1111/j.1651-2227.1997.tb18372.x · Cited by 50
Reus, L., van Vlimmeren, L. A., Staal, J. B., Otten, B. J., & der Sanden, M. W. G. N. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.05.005 · Cited by 50
Whitman, B. Y., Carrel, A. L., Bekx, T., et al. (2004) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2004.17.4.591 · Cited by 48
Five‐years growth hormone (GH) treatment in adults with Prader‐Willi syndrome
Höybye, C. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2006.00051.x · Cited by 47
Self-citationFarholt, S., Sode-Carlsen, R., Christiansen, J. S., Østergaard, J. R., & Höybye, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0782 · Cited by 47
Self-citationOutcome of Biliopancreatic Diversion in Subjects with Prader-Willi Syndrome
Marinari, G. M., Camerini, G. B., Novelli, G. B., Papadia, F. S., Murelli, F., Marini, P., Adami, G., & Scopinaro, N. (2001) · Obesity Surgery · doi:10.1381/096089201321209404 · Cited by 46
Normal Cortisol Response on Low-Dose Synacthen (1 μg) Test in Children with Prader Willi Syndrome
Nyunt, O., Cotterill, A. M., Archbold, S. M., Wu, J. Y., Leong, G. M., Verge, C. F., Crock, P., Ambler, G. R., Hofman, P. L., & Harris, M. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0647 · Cited by 45
The GH/IGF-I Axis and Pituitary Function and Size in Adults with Prader-Willi Syndrome
van Nieuwpoort, I. C., Sinnema, M., Castelijns, J. A., Twisk, J. W. R., Curfs, L., & Drent, M. L. (2011) · Hormone Research in Paediatrics · doi:10.1159/000323442 · Cited by 44
Feigerlová, E., Diene, G., Petit, I., Gennero, I., Salles, J., Arnaud, C., & Tauber, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1831 · Cited by 44
Self-citationGrowth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome
Sode-Carlsen, R., Farholt, S., Rabben, K. F., Bollerslev, J., Schreiner, T., Jurik, A. G., Frystyk, J., Christiansen, J. S., & Höybye, C. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.05.002 · Cited by 43
Self-citationLong-Term Experience with Duodenal Switch in Adolescents
Marceau, P., Marceau, S., Biron, S., Hould, F., Lebel, S., Lescelleur, O., Biertho, L. D., & Kral, J. G. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0262-4 · Cited by 43
The growth hormone-insulin-like growth factor axis in adult patients with Prader Willi syndrome
Höybye, C., Frystyk, J., & Thorén, M. C. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00017-0 · Cited by 40
Self-citationDeath during GH therapy in children with Prader-Willi syndrome: Description of two new cases
Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology, Grugni, G., Livieri, C., Corrias, A., Sartório, A., & Crinò, A. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347245 · Cited by 39
van Wijngaarden, R. F. A. D. L., Festen, D. A. M., Otten, B. J., van Mil, E., Rotteveel, J., Odink, R. J., van Leeuwen, M., Haring, D. A. J. P., Bocca, G., Houdijk, E. C. A. M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0270 · Cited by 39
Festen, D. A. M., van Toorenenbergen, A. W., Duivenvoorden, H. J., & Hokken‐Koelega, A. C. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2241 · Cited by 38
Abnormal ventilatory responses in patients with Prader-Willi syndrome
Menendez, A. A. (1999) · European Journal of Pediatrics · doi:10.1007/s004310051247 · Cited by 37
Specific treatment of Prader–Willi syndrome through cyclical rehabilitation programmes
Grolla, E., Andrighetto, G., Parmigiani, P., Hladnik, U., Ferrari, G., Bernardelle, R., Lago, M. D., Albarello, A., Baschirotto, G., Filippi, G., et al. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2010.549288 · Cited by 37
Growth Failure in Prader-Willi Syndrome Is Secondary to Growth Hormone Deficiency
Thacker, M. J., Hainline, B. E., Feezle, L. K. S.-D., Johnson, N. B., & Pescovitz, O. H. (1998) · Hormone Research in Paediatrics · doi:10.1159/000023174 · Cited by 36
Marzullo, P., Marcassa, C., Campini, R., Eleuteri, E., Minocci, A., Sartório, A., Vettor, R., Liuzzi, A., & Grugni, G. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0600 · Cited by 36
Wysokiński, A., Kowman, M., & Kłoszewska, I. (2012) · PubMed · Cited by 34
The effect of growth hormone on sleep‐related cardio‐respiratory control in Prader–Willi syndrome
Katz‐Salamon, M., Lindgren, A., & Cohen, G. (2012) · Acta Paediatrica · doi:10.1111/j.1651-2227.2012.02638.x · Cited by 34
Papavramidis, T. S., Kotidis, E. V., & Gamvros, O. (2006) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2006.01.065 · Cited by 32
Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome
Motaghedi, R., Diaz, E. G. L., Hogg, J., Christos, P. J., Vogiatzi, M. G., & Angulo, M. (2010) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2010.09.015 · Cited by 32
van Wijngaarden, R. F. A. D. L., Cianflone, K., Gao, Y., Leunissen, R. W. J., & Hokken-Koelega, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0656 · Cited by 32
Riedl, S., Blümel, P., Zwiauer, K., & Frisch, H. (2005) · Acta Paediatrica · doi:10.1080/08035250510027110 · Cited by 31
Use of Somatostatin Analogues in Obesity
Tzotzas, T., Papazisis, K., Perros, P., & Krassas, G. E. (2008) · Drugs · doi:10.2165/00003495-200868140-00003 · Cited by 30
Sudden Death in Prader-Willi Syndrome: Brief Review of Five Additional Cases
Bakker, E., Maneatis, T. J., & Lippe, B. M. (2006) · Hormone Research in Paediatrics · doi:10.1159/000097928 · Cited by 30
Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome
Grugni, G., Crinò, A., Pagani, S., Meazza, C., Buzi, F., Toni, T. D., Gargantini, L., Pilotta, A., Pozzan, G. B., Radetti, G., et al. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.269 · Cited by 29
Physical effects of growth hormone treatment in children with Prader‐Willi syndrome
Myers, S., Carrel, A., Whitman, B., & Allen, D. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb14417.x · Cited by 29
Self-citationGrugni, G., Giardino, D. L., Crinò, A., Malvestiti, F., Ballarati, L., Giorgio, G. D., & Marzullo, P. (2011) · Journal of Endocrinological Investigation · doi:10.3275/7203 · Cited by 26
Höybye, C. (2006) · Hormone Research in Paediatrics · doi:10.1159/000093229 · Cited by 23
Self-citationEiholzer, U., Meinhardt, U. J., Rousson, V., Petrovic, N., Schlumpf, M., & l’Allemand, D. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32137 · Cited by 21
Body fat excess and stimulated growth hormone levels in adult patients with Prader–Willi syndrome
Grugni, G., Crinò, A., Bertocco, P., & Marzullo, P. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32713 · Cited by 20
Reports of Increased Mortality and GH: Will This Affect Current Clinical Practice?
Malozowski, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3363 · Cited by 16
Galassetti, P. R., Opgaard, O. S., Cassidy, S. B., & Pontello, A. M. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.4.491 · Cited by 14
Benefit of Early Commencement of Growth Hormone Therapy in Children with Prader-Willi Syndrome
Nyunt, O., Harris, M., Hughes, I. P., et al. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.12.1151 · Cited by 14
Eiholzer, U., Meinhardt, U. J., Gallo, C., Schlumpf, M., Rousson, V., & l’Allemand, D. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.08.008 · Cited by 12
Cited by
Styne, D. M., Arslanian, S. A., Connor, E. L., Farooqi, I. S., Murad, M. H., Silverstein, J. H., & Yanovski, J. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2573 · Cited by 1,282
Butyrate: A Double-Edged Sword for Health?
Liu, H., Wang, J., He, T., Becker, S., Zhang, G., Li, D., & Ma, X. (2018) · Advances in Nutrition · doi:10.1093/advances/nmx009 · Cited by 1,144
Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings
Angulo, M. A., Butler, M. G., & Cataletto, M. E. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0312-9 · Cited by 601
Genomic imprinting disorders: lessons on how genome, epigenome and environment interact
Monk, D., Mackay, D. J. G., Eggermann, T., Maher, E. R., & Riccio, A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0092-0 · Cited by 443
Collett-Solberg, P. F., Ambler, G., Backeljauw, P. F., Bidlingmaier, M., Biller, B. M. K., Boguszewski, M. C. S., Cheung, P. T., Choong, C. S. Y., Cohen, L. E., Cohen, P., et al. (2019) · Hormone Research in Paediatrics · doi:10.1159/000502231 · Cited by 360
Self-citation
Metadata
- Authors
- Deal, C. L., Tony, M., Höybye, C., Allen, D. B., Tauber, M., Christiansen, J. S., & Participants, T. 2. G. H. I. P.-W. S. C. C. G. W.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-06-01
- Volume
- 98
- Issue
- 6
- Pages
- E1072-E1087
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2166152082
- Cited by
- 379
- References
- 133
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.